A key lesson learned in 2020 was the importance of rapid discovery of novel molecules and transition into scale up. Advancement of technologies in flow chemistry and control systems have enabled Discovery Chemists, Process Chemists, PAT and Engineers to adopt flow chemistry to uncover previously inaccessible APIs and synthetic molecules – with a much more streamlined development process, in addition to the increased emphasis of green chemistry.
The 2nd Annual Commercializing Flow Chemistry Summit will return to bridge the gap between academic and industry innovation this August, as the only truly application focused event, to translate exciting theory into commercial reality. Joined by 100+ senior leaders from large pharma, biotech, academia; including exploration outside of pharma for the first time.
Don’t miss out on this unique opportunity to go beyond on the bench and make real impact to your company.
Drug Developers & Chemicals - 2 Day Conference + 2 Deep Dives + Seminar Day USD 3495.00
Drug Developers & Chemicals - 2 Day Conference + 2 Deep Dives USD 2792.00
Drug Developers & Chemicals - 2 Day Conference + Seminar Day USD 2792.00
Drug Developers & Chemicals - Conference Only USD 2099.00
Flow Chemistry Solution Provider - 2 Day Conference + 2 Deep Dives + Seminar Day USD 4195.00
Flow Chemistry Solution Provider - 2 Day Conference + 2 Deep Dives USD 3397.00
Flow Chemistry Solution Provider - 2 Day Conference + Seminar Day USD 3397.00
Flow Chemistry Solution Provider - Conference Only USD 2599.00
Cross-Industry & Academic - 2 Day Conference + 2 Deep Dives + Seminar Day USD 3095.00
Cross-Industry & Academic - 2 Day Conference + 2 Deep Dives USD 2497.00
Speakers: Moiz Diwan Director, Head of Enabling Technology Development Group AbbVie, Onkar Manjrekar Senior Scientist AbbVie, Ryan Chung Senior Scientist AbbVie, Nayantara Kosaraju Flow Engineer Adesis, Inc, Neil Langille Principal Scientist Amgen, Christian Holtze Senior Engineer - Research, Flow Chemistry & Academic Partnership Developer BASF, Brenden Lee Director, Business Development Birdotech, Kimberly Ellis Scientist, Integrated Drug Substance Development Codiak BioSciences, John Williams Process Technology Development Expert CPI, Ayman Allian Engineering Advisor Eli Lilly and Company, Jennifer Groh Associate Sr Consultant Engineer Synthetic Molecule Design and Development Eli Lilly and Company, Martin Johnson Senior Engineering Advisor, Process Design and Development Eli Lilly and Company, Dimitris Kyprianou Scientific Project Officer, Joint Research Centre (JRC) European Commission, Paolo Tosatti Senior Scientist, Process Chemistry and Catalysis F. Hoffmann-La Roche, René Lebl Post Doctorate Scientist F. Hoffmann-La Roche, Andrew Hague Principal Development Scientist Immunogen, Milad Abolhasani Assistant Professor of Chemical & Biomolecular Engineering North Carolina State University, Jenson Verghese Senior Scientist, FAST Pfizer, David Cantillo Assistant Professor Research Center Pharmaceutical Engineering GmbH (RCPE) University of Graz, Jin-Ping Lim Program Director Advanced Manufacturing SRI Biosciences, SRI International, Nathan Collins Chief Strategy Officer SRI BioSciences, SRI International, Claudio Battilocchio Team Leader Flow Chemistry Process Research Syngenta Crop, Michael Organ Professor University of Ottawa, Timothy Noël Full Professor, Chair of Flow Chemistry Van ‘t Hoff Institute for Molecular Sciences University of Amsterdam, Naomi Briggs Vice President Research & Development On Demand Pharmaceuticals, Ed Masson Process Engineer GSK, Lee Edwards Investigator, Associate Fellow, Primary Continuous Manufacturing GSK, Luke Rogers Vice President, Innovation On Demand Pharmaceuticals, Flavien Susanne Head of Chemical Development and Engineering Sanofi, Oliver Kappe Professor, Scientific Director University of Graz, Center for Continuous Flow Synthesis & Processing (CC FLOW)
Time: On Tuesday August 24, 2021 at 8:30 am (ends Thursday August 26, 2021 at 5:30 pm)